One study has shown that the use of antagonists of the renin–angiotensin–aldosterone system in diabetes contributes to a poor prognosis for COVID-19, and treatment of COVID-19 such as antivirals and corticosteroids may worsen glucose control in diabetics (36). The gene discussed is REN; the disease is COVID-19.